Prevalence of viral markers among first-time Arab blood donors in Kuwait. (Q54302986)

27 May 2018

title

Prevalence of viral markers among first-time Arab blood donors in Kuwait. (English)

1 reference

27 May 2018

author name string

Reem Ameen

1

1 reference

27 May 2018

Nabil Sanad

2

1 reference

27 May 2018

Salem Al-Shemmari

3

1 reference

27 May 2018

Iqbal Siddique

4

1 reference

27 May 2018

Rafiq I Chowdhury

5

1 reference

27 May 2018

Samia Al-Hamdan

6

1 reference

27 May 2018

Abdulaziz Al-Bashir

7

1 reference

27 May 2018

publication date

1 December 2005

1 reference

27 May 2018

published in

Transfusion

1 reference

27 May 2018

volume

45

1 reference

27 May 2018

page(s)

1973-1980

1 reference

27 May 2018

issue

12

1 reference

27 May 2018

A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00635.X

Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00635.X

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00635.X

Residual risk of transfusion-transmitted HCV and HIV infections by antibody-screened blood in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00635.X

The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00635.X

The epidemiology of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00635.X

Antibodies to hepatitis B core antigen and the infectivity of the blood supply. Scientific Section Coordinating Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00635.X

Hepatitis B epidemiology in Asia, the Middle East and Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00635.X

Screening for viral markers in volunteer and replacement blood donors in West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00635.X

Detection of hepatitis B virus DNA by polymerase chain reaction in plasma of volunteer blood donors negative for hepatitis B surface antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00635.X

Do blood donors read and understand screening educational materials?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00635.X

Human immunodeficiency virus type 1-infected blood donors: behavioral characteristics and reasons for donation. The HIV Blood Donor Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00635.X

Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00635.X

Value of anti-HBc screening of blood donors for prevention of HBV infection: results of a 3-year prospective study in Northwestern Greece

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00635.X

Residual risk of transfusion in Ghana

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00635.X

The donor notification process from the donor's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00635.X

Transfusion-transmitted HBV infection in an endemic area: the necessity of more sensitive screening for HBV carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00635.X

10.1111/J.1537-2995.2005.00635.X

21 January 2018

Identifiers

DOI

1 reference

27 May 2018

PubMed ID

16371052

1 reference

27 May 2018